News

Cellectis and Thermo Fisher Scientific announced that they have entered into a series of agreements covering the uses of TAL nucleases under the brand name TALEN™.

Researchers have described an LC–MS/MS method that accurate, precise and is in accordance with FDA guidelines.

HIC-HPLC is a less widely used analytical technique compared with standard methods for separating variants based on size, charge or electrophoretic mobility.

Additional exclusion criterion added to the clinical protocol.

The trial met the primary composite endpoint of hematocrit control and at least a 35 percent reduction in spleen volume.

Limiting saturated fat could help people whose genetic make-up increases their chance of being obese.

A test that counts the number of locations in tumor specimens where tumor cells may invade blood vessels predicted the risk of metastasis for the most common type of breast cancer.

Companies are jointly developing a PD-L1 (SP263) immunohistochemistry assay to enroll patients in clinical trials for MedImmune's MEDI4736 anti-PD-L1 therapy for non-small cell lung carcinoma.

New line of pigs do not reject transplants, which will allow for future research on stem cell therapies.

Significantly expanded relationship created on back of collaboration success.